Update on Clinical Trials for Nonalcoholic Steatohepatitis.
Tremendous effort has been put forth over the past 2 decades in understanding the pathophysiology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH). Although multiple potential targets for drug development exist, there have been no approved therapies for NAFLD/NASH. Lipot...
| Publicado en: | Gastroenterology & Hepatology Vol. 19; no. 7; pp. 371 - 382 |
|---|---|
| Autores principales: | , |
| Formato: | pictorial review tables/charts Journal Article |
| Publicado: |
Gastro-Hep Communications, Inc
Jul2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |